期刊文献+

老年糖尿病患者高尿酸血症与胰岛素抵抗的关系探讨 被引量:2

Investigation on the relationship between hyperuricemia and insulin resistance in senile patients with diabetes mellitus
原文传递
导出
摘要 目的探讨老年糖尿病患者高尿酸血症与胰岛素抵抗的关系。方法老年糖尿病患者75例,按照血尿酸(UA)水平分为高尿酸组(HUA)39例和正常尿酸组(NUA)36例,对两组的BMI、腰臀比(WHR)、血UA、TC、TG、LDL-C、糖化血红蛋白(HbA1c)及胰岛素水平进行分析。结果(1)HUA组TG、TC、LDL-C、胰岛素抵抗指数(HOMA-IR)均高于NUA组[(3.39±1.28)mmol/L与(1.39±0.77)mmol/L、(6.61±1.53)mmol/L与(5.15±1.57)mmol/L、(4.28±1.26)mmol/L与(2.364±1.23)mmol/L、(0.85±0.54)与(0.53±0.38)],差异均有统计学意义(t=2.129、2.012、2.175、2.009,均P〈0.05)。(2)老年糖尿病患者血UA水平与TG、TC、LDL.C及HOMA.IR呈正相关(r=0.327、0.335、0.321、0.331,均P〈0.05)。结论老年糖尿病患者血UA水平与多种因素相关,高尿酸血症与胰岛索抵抗密切相关。 Objective To explore the relationship between hyperuricemia (HUA) and insulin resistance (IR) in senile patients with diabetes mellitus. Methods 75 senile diabetes meUitus patients were divided into HUA group(39 cases) and normal uric acid (NUA) group (36 cases). The clinical data such as BMI,WI-IR,serum UA, TC,TG,LDL-C, HbAlc and insulin level were analyzed. Results The TG, TC,LDL-C, HOMA-IR in HUA group were significantly higher than those in NUA group [ ( 3.39 ±1.28 ) mmol/L vs ( 1.39 ± 0.77 ) mmol/L, ( 6.61 ± 1.53) mmol/L vs (5.15 ± 1.57) retool/L, (4.28± 1.26) mmol/L vs (2.36 ± 1.23 ) mmol/L, (0.85 ± 0.54) vs (0.53 ± 0.38) ] ( t = 2. 129,2. 012,2. 175,2.009, all P 〈 0.05). The level of uric acid was positively correlated with TC ,TG, LDL-C and HOMA-IR in senile diabetes meUitus patients (r = 0. 327,0. 335,0. 321,0. 331, all P 〈 0.05 ). Conclusion The uric acid level of senile diabetes mellitus patients might be related with multiple factors and HUA is closely related with HOMA-IR.
出处 《中国基层医药》 CAS 2014年第3期324-325,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 黑龙江省卫生厅科研课题(2011-661)
关键词 糖尿病 高尿酸血症 胰岛素抗药性 老年人 Diabetes mellitus Hyperuricemia Insulin resistance Aged
  • 相关文献

参考文献10

二级参考文献101

共引文献3091

同被引文献32

  • 1廖伟光,陈协生,李锦萍,廖淑莲.高血压合并无症状高尿酸血症患者降低血尿酸水平对血压影响的对比研究[J].中华临床医师杂志(电子版),2012,6(18):98-101. 被引量:17
  • 2沈赟,陈颖越,金星,蒋兰兰,吴锦丹,马建华.2型糖尿病微血管并发症与高尿酸血症等相关危险因素的分析[J].中华临床医师杂志(电子版),2012,6(21):6919-6921. 被引量:10
  • 3久米村慧,池永武,冈松洋,等.降低血清尿酸水平的组合物发明专利申请公开说明书[P].200480017815.5:1.
  • 4Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension [ J ]. Vasc Health Risk Manag, 2014 , (10) :253-261.
  • 5Kontogianni MD, Chrysohoou C, Panagiotakos DB, et al. Adher- ence to the Mediterranean diet and serum uric acid: the ATYICA study [ J ]. Scand J Rheumatol, 2012,41 (6) :442449.
  • 6Hediger MA, Johnson R J, Miyazaki H, et al. Mo|ecular Physiolo- gy of Urate Transport[J]. Physiology,2005, 20(2) :125-133.
  • 7Hosomi A, Nakanishi T, Fujita T, et al. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2 [ J ]. PLoS One, 2012,7(2) :e30456.
  • 8Vitetta L, Gobe G. Uremia and chronic kidney disease : the role Of the gut microflora and therapies with pro- and prebiotics [ J 1. Mol Nutr Food Res ,2013, 57 ( 5 ) : 824-832.
  • 9Bai YH, Jiang YF, Jiang YS. Lactobacillus bulgaricus mutants decompose uremic toxins[ J ]. Ren Fail, 20!4 ,36 (5) :790-794.
  • 10Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease [ J ]. Adv Ther, 2010,27(9) :634-647.

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部